論文 - 詳細
| RRC ID | 61289 |
|---|---|
| 著者 | Horikawa N, Abiko K, Matsumura N, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Taki M, Ukita M, Hosoe Y, Koshiyama M, Konishi I, Mandai M. |
| タイトル | Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment. |
| ジャーナル | Br J Cancer |
| Abstract |
BACKGROUND:The mechanism of resistance development to anti-VEGF therapy in ovarian cancer is unclear. We focused on the changes in tumour immunity post anti-VEGF therapy. METHODS:The frequencies of immune cell populations and hypoxic conditions in the resistant murine tumours and clinical samples were examined. The expression profiles of both the proteins and genes in the resistant tumours were analysed. The impact of granulocyte-monocyte colony-stimulating factor (GM-CSF) expression on myeloid-derived suppressor cell (MDSC) function in the resistant tumours was evaluated. RESULTS:We found a marked increase and reduction in the number of Gr-1 + MDSCs and CD8 + lymphocytes in the resistant tumour, and the MDSCs preferentially infiltrated the hypoxic region. Protein array analysis showed upregulation of GM-CSF post anti-VEGF therapy. GM-CSF promoted migration and differentiation of MDSCs, which inhibited the CD8 + lymphocyte proliferation. Anti-GM-CSF therapy improved the anti-VEGF therapy efficacy, which reduced the infiltrating MDSCs and increased CD8 + lymphocytes. In immunohistochemical analysis of clinical samples, GM-CSF expression and MDSC infiltration was enhanced in the bevacizumab-resistant case. CONCLUSIONS:The anti-VEGF therapy induces tumour hypoxia and GM-CSF expression, which recruits MDSCs and inhibits tumour immunity. Targeting the GM-CSF could help overcome the anti-VEGF therapy resistance in ovarian cancers. |
| 巻・号 | 122(6) |
| ページ | 778-788 |
| 公開日 | 2020-3-1 |
| DOI | 10.1038/s41416-019-0725-x |
| PII | 10.1038/s41416-019-0725-x |
| PMID | 31932754 |
| PMC | PMC7078258 |
| MeSH | Animals Disease Models, Animal Female Granulocyte-Macrophage Colony-Stimulating Factor / metabolism* Humans Mice Myeloid-Derived Suppressor Cells / metabolism* Ovarian Neoplasms / drug therapy* Ovarian Neoplasms / pathology Vascular Endothelial Growth Factor A / antagonists & inhibitors* |
| IF | 5.791 |
| リソース情報 | |
| ヒト・動物細胞 | OV2944-HM-1(RCB1483) |